Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

This study has been completed.

Study NCT00316563 Information provided by Alberta Cancer Board

First Received: April 19, 2006 Last Updated: November 9, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2009
Estimated Primary Completion Date:	No date given